dobutamine has been researched along with mci 154 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Kitada, Y; Narimatsu, A | 2 |
| Abe, Y; Kitada, Y; Narimatsu, A; Tobe, A | 1 |
| Ohizumi, Y | 1 |
| Mori, M; Takaoka, H; Takeuchi, M; Yokoyama, M | 1 |
| Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamaguchi, K; Yamakawa, H; Yokoyama, M | 1 |
| Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamakawa, H; Yokoyama, M | 1 |
1 review(s) available for dobutamine and mci 154
| Article | Year |
|---|---|
[Tendency of development on novel type of cardiotonic drugs].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Amrinone; Animals; Calcium; Catechols; Dobutamine; Dopamine; Fatty Alcohols; Heart Failure; Humans; Pyridazines; Troponin | 1993 |
1 trial(s) available for dobutamine and mci 154
| Article | Year |
|---|---|
Lusitropic effects of a Ca2+ sensitization with a new cardiotonic agent, MCI-154, on diseased human hearts.
Topics: Adult; Aged; Angina Pectoris; Calcium; Cardiac Catheterization; Cardiotonic Agents; Coronary Disease; Diastole; Dobutamine; Female; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Pyridazines; Stimulation, Chemical; Ventricular Function, Left | 1995 |
5 other study(ies) available for dobutamine and mci 154
| Article | Year |
|---|---|
Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
Topics: Acidosis; Animals; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Milrinone; Myocardial Contraction; Pyridazines; Pyridones | 1992 |
Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Male; Milrinone; Myocardial Contraction; Myocardium; Pyridazines; Pyridones; Ventricular Function, Left | 1991 |
Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Coronary Vessels; Dobutamine; Dogs; Female; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxygen Consumption; Pyridazines | 1993 |
Beneficial effects of a Ca2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor.
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Humans; Imidazoles; Myocardial Infarction; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Ventricular Dysfunction, Left | 1997 |
Oxygen-saving effect of a new cardiotonic agent, MCI-154, in diseased human hearts.
Topics: Aged; Cardiotonic Agents; Constriction, Pathologic; Coronary Disease; Dobutamine; Energy Metabolism; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Pyridazines; Ventricular Function, Left; Ventricular Pressure | 1997 |